Latest Ranbaxy Laboratories Stories
Research and Markets (http://www.researchandmarkets.com/research/6d2dfc/japan_pharmaceutic) has announced the addition of the "Japan Pharmaceuticals and Healthcare Report Q3 2008" report to their offering.
Research and Markets (http://www.researchandmarkets.com/research/a4c187/romania_pharmaceut) has announced the addition of the "Romania Pharmaceuticals and Healthcare Report Q3 2008" report to their offering.
By The Associated Press WASHINGTON - The government is closing U.S. borders to more than 30 generic drugs - including popular antibiotics and cholesterol medicines - made by India's drug giant Ranbaxy Laboratories because of poor quality in two of its factories.
The U.S. Food and Drug Administration initiated a block on Tuesday of more than 30 generic drugs produced by Ranbaxy Laboratories Ltd. â€“ Indiaâ€™s biggest pharmaceutical company.
The FDA has issued two warning letters to India-based Ranbaxy Laboratories, and an import alert for generic drugs produced by the company's Dewas and Paonta Sahib plants in India.
By Rita Rubin The Food and Drug Administration has issued an "import alert" to block approximately 30 generic drugs made by two plants in India from entering the USA, officials said Tuesday.
The U.S. Food and Drug Administration has issued warning letters and an import alert for generic drugs produced by Ranbaxy Laboratories Ltd. of India. The warning letters identify the FDA's concerns about alleged deviations from U.S.
Speaking before reporters at one of New Delhi's poshest hotels last month, Ranbaxy Laboratories (RANB.BO) CEO and Chairman Malvinder M. Singh was all smiles.
Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, Gurgaon, India, has announced that under an agreement with AstraZeneca Pharmaceuticals it has launched an authorized generic of Omeprazole 40mg capsules in the US healthcare system.
GURGAON, India and PRINCETON, N.J., July 28 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc.
- Growing in low tufty patches.